Skip to main content
Clinical Trials/ACTRN12621001735842
ACTRN12621001735842Not yet recruiting未知

A randomised, controlled comparative study the wrinkle reduction benefits of No-Tox, a plukenetia/niacinamide/plankton-based topical cosmeceutical formulation vs. 0.5 mg (0.05% w/w) tretinoin, a pharmaceutical prescription-strength topical retinoic acid formulation in healthy adults

Skin Surgery Clinic0 sites60 target enrollmentStarted: December 20, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
25 Years to 75 Years (—)
Sex
All

Inclusion Criteria

  • Healthy volunteers, aged between 25 and 75 without acute or chronic skin diseases will be enrolled.

Exclusion Criteria

  • Anyone with skin diseases, acute or chronic, those unable to provide informed consent, or those with a history of allergies or sensitivities to any of the ingredients in the study products. For females, pregnancy (or planned pregnancy during he study period) will also be an exclusion.

Investigators

Sponsor
Skin Surgery Clinic

Similar Trials